Pharmafile Logo
Pharmafocus logo
Advanced Search

MSD

Showing 15 posts of 247 posts found.

Jonathan Emms

Pfizer head to be ABPI president

December 4, 2013
Medical Communications, Sales and Marketing ABPI, MSD, PPRS, Pfizer, Whitehead, emms, khanna

The UK managing director of Pfizer Jonathan Emms is to replace Deepak Khanna as the ABPI president from April next …

News
MSD image

Merck to close Irish plant with loss of 570 jobs

December 2, 2013
Manufacturing and Production, Sales and Marketing Ireland, MSD, Merck, job cuts, swords

Merck & Co has said it plans to close down a facility in Ireland with the loss of around 570 …

News
merck_entrance

MSD’s sugammadex knocked back by FDA – again

September 25, 2013
Research and Development, Sales and Marketing FDA, MSD, Merck, Sugammedex

News
merck_incweb

Merck told to make $1 billion in cuts

August 22, 2013
Sales and Marketing Leerink Swann, MSD, Merck, Odanacatib, sugammadex

News
Merck image

MSD cleared by PMCPA

July 23, 2013
Medical Communications, Sales and Marketing ABPI, MSD, Merck, PMCPA, code

Merck Sharp Dohme has been found not guilty of breaching two clauses in the ABPI Code of Practice – including …

News
januvia image

MSD takes Januvia rap

July 9, 2013
Medical Communications, Sales and Marketing Januvia, MSD, Merck, PMCPA

Merck Sharp & Dohme has been censured by the PMCPA for failing to uphold standards in the way it promoted …

News
Merck image

Aspen buys Merck facility and products in $1 billion deal

July 1, 2013
Manufacturing and Production MSD, Merck, Oss, aspen

Africa’s largest drugmaker Aspen Pharmacare has agreed to buy a manufacturing facility owned by Merck & Co, plus a portfolio …

News
merck image

Merck to close Irish manufacturing unit

March 11, 2013
Manufacturing and Production MSD, Merck

Merck & Co has said that a manufacturing unit in Rathdrum, Ireland will close by the end of 2015 with …

News
Victrelis image

Two hepatitis C drugs win Prix Galien

September 28, 2012
Medical Communications, Sales and Marketing Incivo, Janssen, MSD, Victrelis, prix galien

Two new hepatitis C drugs have been given the 2012 UK Prix Galien innovative product award as joint winners in …

News
Patientslike me image

MSD joins forces with PatientsLikeMe for psoriasis

August 14, 2012
Medical Communications MSD, Novartis, PatientsLikeMe, digital, psoriasis

MSD has teamed up with the online patient community site ‘PatientsLikeMe’ to gauge the impact of psoriasis on patients, whilst …

News
Deepak Khanna

UK drug pricing: ABPI wants evolution, not revolution

June 14, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna, MSD, PPRS, VBP, pricing

 As the ABPI prepares to negotiate a new pricing scheme for the first time in 50 years, its new president …

Feature
Victrelis picture

Two new hep C pills recommended by NICE

April 25, 2012
Sales and Marketing Incivo, Janssen, MSD, NICE, Victrelis, hep C

NICE has given its final recommendation for two new hepatitis C pills in an expedited review.  Janssen’s Incivo (telaprevir) and …

News

Januvia gains renal impairment licence in UK

April 13, 2012
Sales and Marketing Januvia, MSD, Merck, diabetes, renal impairment

Merck’s Januvia has had its licence extended in the UK for patients with moderate to severe renal impairment. The drug …

News
michael_holston-1-3001

Merck appoints new chief ethics and compliance officer

March 30, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Bowles, Holston, MSD, Merck

Merck has announced the appointment of Michael Holston as chief ethics and compliance officer. Holston is to succeed Richard Bowles, …

Appointment

Merck facility reborn as science park

January 11, 2012
Research and Development BioCity, MSD, Merck, Newhouse, Pfizer, Roslin BioCentre, Scotland

A former Merck research site in Scotland has been given a new lease of life as a biotech science park. …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026